There is compelling evidence from family, twin, and adoption studies for a significant genetic component to the etiology of schizophrenia. With the recent revolution in DNA technology, a more direct approach to the localization and identification of susceptibility genes is now possible.
the complex non-Mendelian patterns of transmission observed in multiply affected families.
DOPAMINE RECEPTORS
Disturbances in dopamine neurotransmission have been implicated in the pathogenesis of schizophrenia, primarily on the basis of two observations. First, dopaminergic agonists such as amphetamine can induce a psychosis which mimics schizophrenia and, second, antipsychotic drugs are dopamine receptor antagonists.
Five dopamine receptors have been isolated and each has been considered a target for the candidate gene strategy. Linkage studies of the dopamine DI (1) , dopamine D2 (2) , and dopamine D4 (3) receptor genes have all been essentially negative. The dopamine D3 receptor gene (DRD3) has recently become the focus of particular interest in schizophrenia as it is the target for both typical and the newer atypical antipsychotics. It is also localized to limbic brain structures which have been implicated in the pathogenesis of schizophrenia. Attention has also been directed to the DRD3 by reports that DRD3 rather than DRD2 is up-regulated by both typical and atypical antipsychotics (4, 5) .
Considerable excitement was generated when Lannfelt and colleagues (6) detected a point mutation within exon 1 of DRD3 giving rise to a glycine to serine substitution and creating a Bal I restriction enzyme site. Although no evidence for linkage has been found between schizophrenia and this polymorphism (7), groups in France and the United Kingdom independently found homozygosity in schizophrenic patients (p = 0.005 in the U.K. sample; p = 0.008 in the French sample) (8 (15, 16) . This is of particular interest because VCFS is associated with a higher than normal prevalence of psychosis (17) , which is often schizophrenic in nature (18) .
Several early studies have reported that COMT activity was significantly higher in patients with schizophrenia than in controls (19) (20) (21) (22) , although several subsequent studies have not succeeded in replicating these results (23) (24) (25) (26) (27) . In a recent study, however, Daniels and colleagues (28) found no evidence for allelic association between schizophrenia and a polymorphism determining high or low catechol-Omethyltransferase activity. The power to detect genes of minor effect was low in this study, however, and the study requires replication using a larger sample size.
5-HT2A RECEPTOR
Genes involved in serotonergic neurotransmission have recently become the focus of considerable attention for several reasons. First, lysergic diethylamide (LSD), which has a similar molecular structure to serotonin (5-HT), is known to produce psychosis in healthy subjects (29) . Second, there are relatively consistent findings of altered 5-HT receptor densities and 5-HT metabolism in the brains of patients with schizophrenia (30) . Third, Arranz and colleagues (31) have reported an association between a favorable response to Clozapine (an atypical antipsychotic drug with a high affinity for serotonin receptors) and a polymorphism of the 5-HT2A receptor gene.
The 5-HT2A receptor gene and the surrounding region of chromosome 13 had been effectively excluded as a candidate locus for schizophrenia by a previous linkage study (32) . However, in a large European association study, Williams and colleagues (33) have recently reported that individuals heterozygous or homozygous for the T102C polymorphism of the 5-HT2A receptor gene were at increased risk of schizophrenia. Although the odds ratio is small (1.7), the attributable fraction is large (0.35) as the variant is common. Interestingly, this association has also been replicated in an ethnically distinct population, although in that study the effect was more striking for T102C homozygotes (34) .
Several subsequent studies (using much smaller sample sizes) have failed to replicate this association between T102C and schizophrenia (35) (36) (37) (38) . However, we have combined data from these studies with the data of Williams and colleagues (33) by means of Woolf's analysis (39) . This method allows data from different populations to be combined and provides a means of testing for heterogeneity. The analysis showed that the overall association between schizophrenia and T102C remains significant (p = 0.0008, one-tailed; odds ratio 1.18 [95% confidence interval 0.07-1.32]) (J. Williams, submitted).
How might the 5-HT2A receptor gene and its allelic variant contribute to an increased susceptibility to schizophrenia? As the polymorphism does not alter the amino acid composition of the receptor, it is unlikely that the variant itself is directly causal. One possibility is that the T102C polymorphism may affect the stability or translation of 5-HT2A mRNA and alter the abundance of the expressed receptor (31) . However, Burnett and Harrision (40) were unable to show any relationship between the T102C genotype and receptor abundance.
Another possibility is that this polymorphism is in linkage disequilibrium with another polymorphism in the 5-HT2A receptor gene. Mutational analysis of the entire coding region for the 5-HT2A receptor gene has detected two coding polymorphisms (Thr25Asn and His452Tyr) (41) . However, neither polymorphism showed an allelic association with schizophrenia within a population that showed an association with the T102C polymorphism. It remains a possibility, however, that other polymorphisms may exist in the promoter, in other regulatory regions of the 5-HT2A receptor gene, or indeed in neighboring genes.
CANDIDATE MECHANISMS OF TRANSMISSION
Complex, non-Mendelian patterns of transmission in schizophrenia may be due to a variety of mechanisms including genomic imprinting and dynamic mutations. Recent studies have supported the view that anticipation occurs in multiplex families transmitting schizophrenia (42) (43) (44) In an attempt to identify the specific expanded CAG/CTG locus or loci associated with schizophrenia, Bowen and colleagues (49) adopted an approach using RED and a CAG/CTG polymerase chain reaction (PCR) screening set. They were unable to identify specific loci associated with schizophrenia and have so far excluded 50 loci from the screening set as candidates for expansion in schizophrenia.
CONCLUSIONS
Evidence for a significant genetic contribution to the etiology of schizophrenia has led to a surge of molecular genetic research into the etiology of schizophrenia. Recent candidate gene studies suggest that polymorphisms at the dopamine D3 receptor gene and the 5-HT2A receptor gene confer susceptibility to schizophrenia. In addition, the replicated findings of expanded trinucleotide repeats in schizophrenia suggest a possible mechanism to explain the complex and non-Mendelian patterns of transmission. There is considerable excitement that the large collaborative studies currently underway promise to identify more genes of both major and minor effects over the next number of years.
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